Drugs / GCSF
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03109236 Background | Aug 2017 → Dec 2022 | liver failure | National University Hospital, Singapore | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GCSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03109236 ↗ |
| Route | Subcutaneous | “5 doses of GCSF injection will be injected under the skin on the abdomen” NCT03109236 ↗ |